Insider Shareholders with Direct Ownership of Avidity Biosciences, Inc. (RNA)
This section provides a comprehensive overview of the insiders with direct ownership of Avidity Biosciences, Inc. (RNA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Avidity Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,169,396 | 0 | 2,169,396 $94.7 Million | 1 |
Jun 16, 2020
Added 50.0%
|
|
|
Sarah Boyce
President and CEO |
1,098,500 | 806,046 | 297,163 $13 Million | 41 |
Sep 19, 2024
Added 17.38%
|
|
Michael F Mac Lean
Chief Financial Officer |
439,302 | 349,918 | 94,093 $4.11 Million | 15 |
Nov 06, 2024
Reduced 12.85%
|
|
Teresa Mc Carthy
Chief Human Resources Officer |
211,500 | 100,082 | 94,018 $4.1 Million | 13 |
Nov 18, 2024
Reduced 21.01%
|
|
Troy Edward Wilson
Director |
0 | 100,000 | 89,618 $3.91 Million | 1 |
Dec 22, 2020
Reduced 52.74%
|
|
W. Michael Flanagan
CSTO |
319,000 | 213,129 | 85,389 $3.73 Million | 11 |
Oct 01, 2024
Reduced 42.26%
|
|
John B Moriarty
Chief Legal Officer |
25,000 | 0 | 25,000 $1.09 Million | 1 |
Aug 01, 2024
Added 50.0%
|
|
Arthur A Levin
Director |
276,423 | 262,923 | 14,830 $647,329 | 46 |
Nov 19, 2024
Reduced 18.31%
|
|
Tamar Thompson
Director |
30,000 | 30,000 | 0 $0 | 2 |
Oct 07, 2024
Reduced 100.0%
|